Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2009

01.07.2009 | Article

Nontuberculous mycobacterial infections among patients suspected of pulmonary tuberculosis

verfasst von: H. Grubek-Jaworska, R. Walkiewicz, A. Safianowska, M. Nowacka-Mazurek, R. Krenke, T. Przybyłowski, R. Chazan

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to present a retrospective analysis of the frequency of nontuberculous mycobacteria (NTM)-related pulmonary infections among the AFB-positive and/or culture-positive patients in the Warsaw region who were suspected of tuberculosis (TB) and hospitalized in the university hospital between 1999 and 2005. All the AFB-positive pulmonary samples were examined with a molecular method using the Amplicor MTB test (Roche) for detection of Mycobacterium tuberculosis complex, and all mycobacterial isolates were speciated by high performance liquid chromatography (HPLC) analysis of mycolic acids. Patients who met clinical, radiological, and bacteriological criteria of mycobacteriosis were classified according to the American Thoracic Society (ATS) guidelines for diagnosis of NTM related disease. Among the 445 smear-positive or/and culture-positive patients, 142 subjects (31.9%) were found to be infected with M. tuberculosis. Among 303 non-TB patients, mycobacteriosis was found in 27 (8.9%) subjects. The frequency of NTM-related lung disease as compared to the bacteriologically-confirmed lung TB was estimated at 1:5. The rapid, precise methods of NTM speciation are necessary for progress in diagnostics of NTM related diseases.
Literatur
1.
Zurück zum Zitat Debrunner M, Salfinger M, Brandli O, von Graevenitz A (1992) Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis 15:330–345PubMed Debrunner M, Salfinger M, Brandli O, von Graevenitz A (1992) Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis 15:330–345PubMed
5.
Zurück zum Zitat Adle-Biassette H, Huerre M, Breton G et al (2003) Non tuberculous mycobacterial diseases. Ann Pathol 23:216–235PubMed Adle-Biassette H, Huerre M, Breton G et al (2003) Non tuberculous mycobacterial diseases. Ann Pathol 23:216–235PubMed
6.
Zurück zum Zitat Falkinham JO III (1996) Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9:177–215PubMed Falkinham JO III (1996) Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9:177–215PubMed
7.
Zurück zum Zitat American Thoracic Society (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156:S1–S25 American Thoracic Society (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156:S1–S25
8.
Zurück zum Zitat Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society (2000) Management of opportunist mycobacterial infection: Joint Tuberculosis Committee guidelines 1999. Thorax 55:210–218. doi:10.1136/thorax.55.3.210 Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society (2000) Management of opportunist mycobacterial infection: Joint Tuberculosis Committee guidelines 1999. Thorax 55:210–218. doi:10.​1136/​thorax.​55.​3.​210
10.
Zurück zum Zitat Shitrit D, Priess R, Peled N et al (2007) Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome. Eur J Clin Microbiol Infect Dis 26:679–684. doi:10.1007/s10096-007-0331-3 PubMedCrossRef Shitrit D, Priess R, Peled N et al (2007) Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome. Eur J Clin Microbiol Infect Dis 26:679–684. doi:10.​1007/​s10096-007-0331-3 PubMedCrossRef
11.
Zurück zum Zitat d’Arminio Monforte A, Vago L, Gori A et al (1996) Clinical diagnosis of mycobacterial diseases versus autopsy findings in 350 patients with AIDS. Eur J Clin Microbiol Infect Dis 15:453–458. doi:10.1007/BF01691311 d’Arminio Monforte A, Vago L, Gori A et al (1996) Clinical diagnosis of mycobacterial diseases versus autopsy findings in 350 patients with AIDS. Eur J Clin Microbiol Infect Dis 15:453–458. doi:10.​1007/​BF01691311
13.
Zurück zum Zitat Kanathur N, Shantaveerapa HN, Byrd RP Jr et al (2001) Nontubercular mycobacterial pulmonary infection in immunocompetent men. South Med J 94:719–723PubMed Kanathur N, Shantaveerapa HN, Byrd RP Jr et al (2001) Nontubercular mycobacterial pulmonary infection in immunocompetent men. South Med J 94:719–723PubMed
14.
Zurück zum Zitat Prince DS, Peterson DD, Steiner RM et al (1989) Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 321:863–868PubMed Prince DS, Peterson DD, Steiner RM et al (1989) Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 321:863–868PubMed
15.
20.
Zurück zum Zitat Mehta AC, Prakash UBS et al (2005) American College of Chest Physicians and American Association for Bronchology Consensus Statement: prevention of flexible bronchoscopy-associated infection. Chest 128:742–755. doi:10.1378/chest.128.3.1742 CrossRef Mehta AC, Prakash UBS et al (2005) American College of Chest Physicians and American Association for Bronchology Consensus Statement: prevention of flexible bronchoscopy-associated infection. Chest 128:742–755. doi:10.​1378/​chest.​128.​3.​1742 CrossRef
21.
Zurück zum Zitat Butler WR, Floyd MM, Silcox V et al (1996) Standardized method for HPLC identification of mycobacteria. HPLC users group in cooperation with Centers for Disease Control and Prevention. Atlanta: U.S. Public Health Service, CDC Butler WR, Floyd MM, Silcox V et al (1996) Standardized method for HPLC identification of mycobacteria. HPLC users group in cooperation with Centers for Disease Control and Prevention. Atlanta: U.S. Public Health Service, CDC
22.
Zurück zum Zitat Safianowska A, Walkiewicz R, Grubek-Jaworska H et al (2002) Abstract. Mycolic acids analysis from various species mycobacterium by high pressure liquid chromatography (HPLC). (In Polish). Pneumonol Alergol Pol 70(3–4):130–138 Safianowska A, Walkiewicz R, Grubek-Jaworska H et al (2002) Abstract. Mycolic acids analysis from various species mycobacterium by high pressure liquid chromatography (HPLC). (In Polish). Pneumonol Alergol Pol 70(3–4):130–138
23.
Zurück zum Zitat Kanathur N, Shantaveerapa HN, Byrd RP et al (2001) Nontubercular mycobacterial pulmonary infection in immunocompetent men. South Med J 94:719–723PubMed Kanathur N, Shantaveerapa HN, Byrd RP et al (2001) Nontubercular mycobacterial pulmonary infection in immunocompetent men. South Med J 94:719–723PubMed
24.
25.
Zurück zum Zitat Marinho A, Fernandes G, Carvalho T et al (2005) Nontuberculous mycobacteria in non-aids patients. Rev Port Pneumol 11(6)(Suppl 1):46–47 Marinho A, Fernandes G, Carvalho T et al (2005) Nontuberculous mycobacteria in non-aids patients. Rev Port Pneumol 11(6)(Suppl 1):46–47
28.
Zurück zum Zitat Szczuka I (ed) (2006) Tuberculosis and lung disease in Poland in 2006. National Tuberculosis and Lung Disease Research Institute, Warsaw Szczuka I (ed) (2006) Tuberculosis and lung disease in Poland in 2006. National Tuberculosis and Lung Disease Research Institute, Warsaw
29.
Zurück zum Zitat Polanecký V, Kalina P, Kubín M et al (2006) Nontuberculous mycobacteria and incidence of mycobacterioses in Prague in 1999–2004. Epidemiol Mikrobiol Imunol 55:151–157PubMed Polanecký V, Kalina P, Kubín M et al (2006) Nontuberculous mycobacteria and incidence of mycobacterioses in Prague in 1999–2004. Epidemiol Mikrobiol Imunol 55:151–157PubMed
32.
Zurück zum Zitat Pérez-Martínez I, Ponce-De-León A, Bobadilla M et al (2008) A novel identification scheme for genus Mycobacterium, M. tuberculosis complex, and seven mycobacteria species of human clinical impact. Eur J Clin Microbiol Infect Dis 27:451–459. doi:10.1007/s10096-008-0459-9 PubMedCrossRef Pérez-Martínez I, Ponce-De-León A, Bobadilla M et al (2008) A novel identification scheme for genus Mycobacterium, M. tuberculosis complex, and seven mycobacteria species of human clinical impact. Eur J Clin Microbiol Infect Dis 27:451–459. doi:10.​1007/​s10096-008-0459-9 PubMedCrossRef
Metadaten
Titel
Nontuberculous mycobacterial infections among patients suspected of pulmonary tuberculosis
verfasst von
H. Grubek-Jaworska
R. Walkiewicz
A. Safianowska
M. Nowacka-Mazurek
R. Krenke
T. Przybyłowski
R. Chazan
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2009
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0694-0

Weitere Artikel der Ausgabe 7/2009

European Journal of Clinical Microbiology & Infectious Diseases 7/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.